Immunization

Merck and Moderna’s adjuvant melanoma treatment shows reduced risk of recurrence or death by 44% compared with pembrolizumab alone.

By leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.

Both vaccine hesitancy and antivax beliefs are largely fueled by inaccurate reports of adverse effects from vaccines, a new study finds.

The current flu hospitalization rate is the highest observed this early in a flu season in over a decade.

Jacinda Abdul-Mutakabbir, assistant professor of Pharmacy Practice at Loma Linda University, discusses how pharmacists can improve vaccination rates and learn from the pandemic.

Investigators model 2 hypothetical cities as interconnected networks with a combined population of 100,000 bisexual, gay, and other men who have sex with men.

Defending yourself against the flu and spreading diseases can be as simple as washing your hands.

Flu vaccines can protect against severe outcomes and death, but how long does it last? Who should be getting one?

Walgreens plans to focus on improving pharmacy staffing and retaining and rewarding current staff.

Study results show that patients with moderate or severe immune suppression should be considered a priority for additional vaccine doses and risk-reduction strategies.

CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.

Educating patients while remaining empathetic, sharing personal experiences helps overcome this hurdle.

Australia also experienced their highest flu season in 5 years, which may foreshadow a bad flu season in the Northern Hemisphere.

Our Best Shot (OBS) is a new children’s book explaining why we should get an annual flu shot and it is not something to fear…and adults may even benefit, said the author.

Reemergence of pertussis continues despite high immunization rates.

The seasonal flu vaccine should be prioritized for those with SCN1A-positive Dravet syndrome, because of the likelihood of severe neurological symptoms and complications.

Both of Moderna's bivalent boosters showed neutralizing activity against BQ.1.1, an increasingly dominant emerging variant, confirming that updated vaccines have the potential to offer protection as the virus continues to evolve.

Importance of clear and accurate documentation is emphasized in patient claim for compensation.

In a 2019 survey, middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups, which was not the case in the 2022 survey.

Currently, no national pharmacy organization has defined wellness in the pharmacy profession, which is needed so that others have a sense of guidance around wellness within the profession.

The book aims to make the vaccination process less scary and allow more children to be vaccinated.

Analysis includes an overview of the epidemiology, expression, and treatment of human papillomavirus infections during both gestation and childhood.

The pharmacy industry operates through people with different talents filling all types of responsibilities.

Leaders must fully understand the benefits of diversity and create an environment in which it thrives to cultivate and inspire the next generation of inclusive leaders.

American Society of Consultant Pharmacists executive director and CEO explained how staffing struggles in long-term care facilities can be an opportunity for pharmacists to expand the ways they provide support beyond immunizations alone.

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

Infection with RSV can take a variety of forms, ranging from a mild upper respiratory tract infection to severe, life-threatening acute respiratory failure.

Study results indicate durable immune response from bivalent booster after 3 months of follow-up.

The Moderna mRNA-1273 vaccine was found to be effective for more than 50% of children aged 6 to 23 months.